For example: interferon-gamma (IFNγ) released by CD8+ T cells can down-regulate the expression of SLC3A2 and SLC7A1 in tumor cells, inhibiting the uptake of cystine, limiting tumor development and improving patient prognosis. Here, SLC7A1 is linked to neoplasm.